DEBATE: ALL Asymptomatic Carotid Stenosis (ACS) Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good And Should Not Be Reimbursed

DEBATE: The Case Against Carotid Screening: It Leads To Unneeded And Possibly Harmful Treatment

LDL-C Lowering Should Be Maximized With High Dose Statins And Ezetimibe (Zetia) To Minimize Risks From Atherosclerotic Lesions: The LDL-C Level Cannot Be Too Low And Side Effects Are Minor: LDL-C Levels Must Be Monitored And Treated To A Target Level

DEBATE: There Should Be No Reimbursement For Carotid Stenting (CAS Or TCAR) For Asymptomatic Patients

DEBATE: Not So: Even Young Patients With A High-Grade ACS Should Not Be Treated By CAS Or CEA